卡泊三醇倍他米松软膏两种剂型的治疗等效性：一项针对成年慢性斑块状银屑病患者的多中心、随机、双盲研究 - Suppr | 超能文献

Therapeutic equivalence of two formulations of calcipotriol-betamethasone ointment: a multicentre, randomized, double-blind study in adult patients with chronic plaque psoriasis.

作者信息

Habjanic N, Koytchev R, Yankova R, Kerec-Kos M, Grabnar-Peklar D

机构信息

Clinical Development, Sandoz Development Center, Lek Pharmaceuticals d.d., Verovškova 57, 1526, Ljubljana, Slovenia.

CCDRD AG, Hoppegarten, Germany.

出版信息

Br J Dermatol. 2018 Nov;179(5):1189-1191. doi: 10.1111/bjd.16913. Epub 2018 Aug 16.

DOI:10.1111/bjd.16913

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Therapeutic equivalence of two formulations of calcipotriol-betamethasone ointment: a multicentre, randomized, double-blind study in adult patients with chronic plaque psoriasis.卡泊三醇倍他米松软膏两种剂型的治疗等效性：一项针对成年慢性斑块状银屑病患者的多中心、随机、双盲研究

Br J Dermatol. 2018 Nov;179(5):1189-1191. doi: 10.1111/bjd.16913. Epub 2018 Aug 16.

2

A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris.一种新的钙泊三醇/倍他米松二丙酸酯制剂（达力士倍他米松）是寻常型银屑病的一种有效的每日一次治疗药物。

Dermatology. 2002;205(4):389-93. doi: 10.1159/000066440.

3

Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.卡泊三醇/倍他米松二丙酸酯软膏和卡泊三醇软膏每日一次治疗寻常型银屑病的疗效

Br J Dermatol. 2004 Jun;150(6):1167-73. doi: 10.1111/j.1365-2133.2004.05986.x.

4

A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris.一种作用起效迅速的新钙泊三醇/倍他米松制剂在寻常型银屑病治疗中优于倍他米松二丙酸酯或钙泊三醇单药治疗。

Acta Derm Venereol. 2002;82(2):131-5. doi: 10.1080/00015550252948194.

5

Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy.在局部银屑病治疗中，骨化三醇的治疗效果持续性优于二丙酸倍他米松。

J Dermatolog Treat. 2003 Jan;14(1):8-13. doi: 10.1080/09546630305545.

6

Calcipotriol/betamethasone ointment compared to narrow-band UVB in plaque psoriasis: first clinical and ultrasonographic study.钙泊三醇/倍他米松软膏与窄谱 UVB 在斑块状银屑病中的比较：首次临床和超声研究。

Int J Dermatol. 2019 Jan;58(1):108-113. doi: 10.1111/ijd.14150. Epub 2018 Aug 2.

7

Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.卡泊三醇/倍他米松二丙酸酯（达力士倍他米松）与卡泊三醇（达力士）治疗寻常型银屑病的疗效、安全性及生活质量：一项随机、多中心临床试验

J Dermatolog Treat. 2007;18(6):361-5. doi: 10.1080/09546630701646156.

8

Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris.与他卡西醇相比，卡泊三醇/倍他米松二丙酸酯每日一次治疗后单用卡泊三醇治疗寻常型银屑病的成本效益。

Dermatology. 2005;211(2):139-45. doi: 10.1159/000086444.

9

A Cost-utility Analysis of Calcipotriol/Betamethasone Dipropionate Aerosol Foam versus Ointment for the Topical Treatment of Psoriasis Vulgaris in Sweden.钙泊三醇/倍他米松二丙酸酯气雾剂与软膏治疗瑞典寻常型银屑病的成本-效用分析。

Acta Derm Venereol. 2019 Apr 1;99(4):393-399. doi: 10.2340/00015555-3112.

10

Calcipotriol/betamethasone dipropionate ointment in mild-to-moderate paediatric psoriasis: long-term daily clinical practice data in a prospective cohort.卡泊三醇/倍他米松二丙酸酯软膏治疗轻中度儿童银屑病：前瞻性队列中长期日常临床实践数据。

Br J Dermatol. 2014 Aug;171(2):363-9. doi: 10.1111/bjd.12895. Epub 2014 Jun 6.

引用本文的文献

1

Sensitivity of Different In Vitro Performance Tests and Their In Vivo Relevance for Calcipotriol/Betamethasone Ointment.不同体外性能测试的敏感性及其与卡泊三醇/倍他米松软膏的体内相关性。

Pharm Res. 2020 Feb 10;37(3):52. doi: 10.1007/s11095-020-2766-5.